From an internal series of 7119 melanomas that had undergone prior hybrid capture-based DNA sequencing, 40 cases (0.6%), each from a different patient, featured gene rearrangements that created known or likely activating structural variants in RAF1, defined as loss of the autoinhibitory domain but retention of the kinase domain. Here, RAF1 is linked to melanoma.